![](https://npr.brightspotcdn.com/dims4/default/827d173/2147483647/strip/true/crop/2432x3243+946+0/resize/150x200!/quality/90/?url=https%3A%2F%2Fmedia.npr.org%2Fassets%2Fimg%2F2020%2F03%2F19%2Fmmorgan_200311_8449-crop-bc62893a9a9758f13973198bd18d3aa7e91be6d7.jpg)
Nurith Aizenman
[Copyright 2024 NPR]
-
Tuberculosis kills 1.6 million a year — the second deadliest infectious disease after COVID-19. Using immune cells and mRNA technology, scientists in South Africa are working on a new vaccine.
-
That's the view of Joseph Glauber of the International Food Policy Research Institute. He considers the fear the war would lead to a surge in food prices – and a dramatic worsening of world hunger.
-
The mRNA shots against COVID were a game-changer but the shots need ultra-cold freezers that are unavailable in many low-income countries. Now the hunt is on for innovations to solve this problem.
-
The South African-based scientist who co-discovered the omicron variant of COVID-19 makes an intriguing argument.
-
Disease researchers from South Africa were the first to identify the omicron variant of the COVID-19 virus. Scientists there are racing to detect new pathogens before they can spark another pandemic.
-
Afrigen is the linchpin of global project to use mRNA technology to empower low-resource countries to make their own vaccines against killer diseases from TB to HIV. What will it take to succeed?
-
Dr. Gabriela Kucharski's city of Toledo had virtually no vaccines. And it's a bastion of support for Brazil's vaccine skeptic president. Here's why that didn't matter.
-
Can we end poverty, provide food for all and otherwise make Earth a better place by 2030? By all accounts, the answer is no. So then what's the point of the Sustainable Development Goals?
-
Only one company makes the currently used monkeypox vaccine. Supply is limited in wealthy nations like the U.S. Less well-off nations, like Nigeria, where the outbreak began, have no vaccines at all.
-
How Sotiris Missailidis, head of R&D in Brazil's vaccine agency, used the COVID crisis to push through a game-changing effort for middle-income countries to invent their own mRNA vaccine.